Analytical Diagnostic Solutions Inc Profile last edited on: 9/1/23
CAGE: 6XC51
UEI: QNDYVJB4AQG3
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 03
County: Burlington
Congr. District: 03
County: Burlington
Public Profile
A puzzle: Originally entered into the SBIR systems as Analytical Diagnostic Solutions - and recorded as successfully in receipt of other awards to include a creditable Phase II track record -- bringing the firm into a multi-million operation - along the way the firm appears to have changed its name to "In Vitro Diagnostic Solutions" - still in New Jersey but relocated and with an expanded staff.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
5-9Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2023 | 2 | NIH | $4,531,714 | |
| Project Title: A user-friendly point-of-care device for G6PDH determination | ||||
| 2023 | 1 | NIH | $295,923 | |
| Project Title: A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now | ||||
| 2023 | 1 | NIH | $291,361 | |
| Project Title: PKU Now-Connect: An intelligent digital ecosystem to improve health outcomes in Phenylketonuria | ||||
| 2023 | 1 | NIH | $300,000 | |
| Project Title: ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2) | ||||
| 2021 | 2 | NIH | $2,171,657 | |
| Project Title: A Point-Of-Care Device for Phenylalanine Determination | ||||
Key People / Management
Robert Harper -- Founder, President & CEO
Company News
There are no news available.
